| Description | Obicetrapib sodium is a cholesteryl ester transfer protein (CETP) inhibitor. CETP inhibitors substantially increase the concentration of high-density lipoprotein cholesterol (HDL-C), which may have a possible beneficial effect for cardiovascular disease risk reduction. |
| molecular weight | 744.59 |
| Molecular formula | C32H30F9N4NaO5 |
| CAS | 866399-88-4 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |